NCATS Advisory Council
According to its charter, the NCATS Advisory Council provides guidance, consults and makes recommendations to the secretary of Health and Human Services, the NIH director and to the NCATS director on Center initiatives, policies and programs. It also conducts a second-level review of scientific grant applications and discusses concept clearances for potential NCATS initiatives.
The NCATS Advisory Council is comprised of appointed members who serve four-year terms.
The Executive Secretary establishes Advisory Council Subcommittees and Working Groups to investigate and provide recommendations and guidance related to specific topics of interest to NCATS.
In 2013, NCATS established the Advisory Council Working Group on the IOM CTSA Program Report to provide advice on changes to the Clinical and Translational Science Awards (CTSA) program, with a focus on establishing measurable goals and objectives.
General Operating Procedures
Advisory Councils at the NIH provide second-level review of all grant applications under consideration for Institute or Center funding. Each Council is required to establish general operating procedures for the review of grant applications.
The NCATS Advisory Council meets three times each year. View the schedule below for upcoming meetings, which are typically videocast; past meeting minutes, agendas and videocasts also are available.
8:30 a.m. to 5:00 p.m.
National Institutes of Health
Building 31C, 6th Floor, Conference Room 10
Bethesda, Md. 20892
This joint meeting of the National Center for Advancing Translational Sciences Advisory Council and the Cures Acceleration Network (CAN) Review Board will feature presentations by NCATS leadership, the CAN Review Board and invited guests. The meeting will feature a Director’s Report, a presentation by the NCATS Advisory Council Working Group on the IOM CTSA Program Report, and proposed CAN initiatives for Fiscal Year 2015. Council subcommittees also will report on 1) patient engagement; 2) partnerships with pharmaceutical and biotechnology companies, and venture capital firms; and 3) medical technologies. In addition, NCATS staff will present a Concept Clearance of proposed initiatives for consideration and approval by Council.
On Sept. 16, 2013, NCATS Director Christopher P. Austin, M.D., led a joint meeting of the NCATS Advisory Council and Cures Acceleration Network Review Board.